Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S269700
Reexamination Certificate
active
07863300
ABSTRACT:
A novel process for preparing thiazolidinediones, preferably Pioglitazone, as described. Also described are novel intermediates involved in its synthesis and process for their preparation and use in medicine.
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4438141 (1984-03-01), Kawamatsu et al.
patent: 4444779 (1984-04-01), Kawamatsu et al.
patent: 4687777 (1987-08-01), Meguro et al.
patent: 4812570 (1989-03-01), Meguro et al.
patent: 4898947 (1990-02-01), Meguro et al.
patent: RE36575 (2000-02-01), Meguro et al.
patent: 2006/0167061 (2006-07-01), Pandey et al.
patent: 2008/0004446 (2008-01-01), Pandey et al.
patent: 0008203 (1980-02-01), None
patent: 0193256 (1986-09-01), None
patent: 0257781 (1988-03-01), None
patent: 93/22445 (1993-11-01), None
patent: 02/88120 (2002-11-01), None
Momose et al. “Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds” Chem. Pharm. Bull. 39:1440-1445 (1991).
Sohda et al. “Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)-benzyl]-2,4-thiazolidinediones” Arzneim.-Forsch. Drug Research 40(I):37-42, (1990).
Int'l Search Report for PCT/IN2003/00241 completed Jan. 22, 2004.
Written Opinion for PCT/IN2003/00241 mailed Apr. 6, 2004.
Int'l Preliminary Examination Report for PCT/IN2003/00241 completed Oct. 20, 2004.
Lohray Braj Bhushan
Lohray Vidya Bhushan
Pandey Bipin
Cadila Healthcare Limited
Morris Patricia L
Nixon & Vanderhye P.C.
LandOfFree
Process to prepare pioglitazone via several novel intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process to prepare pioglitazone via several novel intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process to prepare pioglitazone via several novel intermediates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2736820